P162 Contralateral Breast Cancer in BRCA 1 vs 2 Mutation Carriers

P162 Contralateral Breast Cancer in BRCA 1 vs 2 Mutation Carriers

Bibliographic Details
Main Authors:	A. Girardi, G. Corso, F. Magnoni, A.M. De Scalzi, V. Tagliaferri, E. Bottazzoli, B. Bianchi, P. Veronesi
Format:	Article
Language:	English
Published:	Elsevier 2023-03-01
Series:	Breast
Online Access:	http://www.sciencedirect.com/science/article/pii/S0960977623002795

Similar Items

Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
by: Phillips KA, et al.
Published: (2012-04-01)

Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study
by: Delal Akdeniz, et al.
Published: (2022-02-01)

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
by: Ellen Warner
Published: (2018-11-01)

Surgical Management of Inherited Breast Cancer: Role of Breast-Conserving Surgery
by: Francesca Magnoni, et al.
Published: (2022-07-01)

Is metaplastic breast cancer more aggressive than “classic” triple-negative ductal carcinoma? Recent prognostic and therapeutic consideration
by: A. Girardi, et al.
Published: (2021-04-01)

Multifocal breast cancers are more prevalent in BRCA2 versus BRCA1 mutation carriers
by: Alan D McCrorie, et al.
Published: (2020-04-01)

Molecular biological subtypes of breast cancer in BRCA1 mutation carriers
by: N. I. Pospekhova, et al.
Published: (2021-01-01)

Comparison of Clinicopathological Characteristics Between Primary and Contralateral Cancers in BRCA1/2 Carriers with Metachronous Bilateral Breast Cancers
by: DING Xinyun, et al.
Published: (2023-07-01)

Management of the asymptomatic BRCA mutation carrier
by: Paige Teller, et al.
Published: (2010-11-01)

Pregnancy after breast cancer in BRCA1/2 mutation carriers
by: Jelena Maksimenko, et al.
Published: (2022-01-01)

HIF-1α overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers.
by: Petra van der Groep, et al.
Published: (2013-01-01)

Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.
by: Cox, D, et al.
Published: (2011)

Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers
by: Stawicka Małgorzata, et al.
Published: (2008-04-01)

RANKL/OPG in Breast Cancer — Extending Its Territory to BRCA Mutation Carriers
by: Tilman D. Rachner, et al.
Published: (2015-10-01)

No Sib Pair Concordance for Breast or Ovarian Cancer in <it>BRCA1 </it>Mutation Carriers
by: Møller Pål, et al.
Published: (2007-06-01)

Discussion on the use of taxanes for treatment of breast cancers in <it>BRCA1 </it>mutations carriers
Published: (2007-09-01)

Dermatological and Dermoscopic Baselines in BRCA Mutation Carriers
by: Giovanni Paolino, et al.
Published: (2022-04-01)

Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in <i>BRCA1/BRCA2</i> Mutation Carriers Versus Non-Carriers
by: Michal Vocka, et al.
Published: (2019-05-01)

Prophylactic adnexectomy in BRCA1 and BRCA2 gene mutation carriers (а review of literature)
by: T. A. Shendrikova, et al.
Published: (2014-07-01)

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
by: Juliette Coignard, et al.
Published: (2021-02-01)

Contralateral risk-reducing local therapy in breast cancer patients with BRCA1/2 mutations: systemic review and meta-analysis
by: Ziqi Jia, et al.
Published: (2021-09-01)

Risk-Reducing Breast and Gynecological Surgery for BRCA Mutation Carriers: A Narrative Review
by: Serena Bertozzi, et al.
Published: (2023-02-01)

Effects of Radiation Therapy on Breast Epithelial Cells in BRCA1/2 Mutation Carriers
by: Huai-Chin Chiang, et al.
Published: (2015-06-01)

Characteristics of breast cancer in BRCA1/BRCA2 mutation carriers and non-carriersfrom a genetic counseling unit in Croatia
by: Snježana Ramić, et al.
Published: (2020-01-01)

miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil
by: Danielle Pessôa-Pereira, et al.
Published: (2020-02-01)

Aromatase expression is increased in <it>BRCA1 </it>mutation carriers
by: Chand Ashwini L, et al.
Published: (2009-05-01)

Breast cancer surveillance for BRCA1/2 mutation carriers – is “early detection” early enough?
by: Rinat Bernstein-Molho, et al.
Published: (2020-02-01)

Worse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis.
by: Alexandra J van den Broek, et al.
Published: (2015-01-01)

Cisplatin in breast cancer treatment in BRCA1 carriers
by: Gronwald Jacek, et al.
Published: (2012-12-01)

Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patients
by: Linda Vidarsdottir, et al.
Published: (2023-11-01)

Selenium and genotypes as marker of risk in BRCA1 mutation carriers
by: Jaworska K, et al.
Published: (2012-01-01)

Matched cohort study of germline BRCA mutation carriers with triple negative breast cancer in brightness
by: Otto Metzger-Filho, et al.
Published: (2021-11-01)

Current guidelines for BRCA testing of breast cancer patients are insufficient to detect all mutation carriers
by: Eli Marie Grindedal, et al.
Published: (2017-06-01)

Rapid detection of carriers with <it>BRCA1 </it>and <it>BRCA2 </it>mutations using high resolution melting analysis
by: Fox Stephen B, et al.
Published: (2008-02-01)

Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
by: Juliette Coignard, et al.
Published: (2021-05-01)

Breast cancer risk in BRCA mutation carriers after diagnosis of epithelial ovarian cancer is lower than in carriers without ovarian cancer
by: Andrea Nañez, et al.
Published: (2022-02-01)

Overview on population screening for carriers with germline BRCA mutation in China
by: Huijun Lei, et al.
Published: (2022-11-01)

Selected aspects of genetic counselling for <it>BRCA1 </it>mutation carriers
by: Gronwald Jacek
Published: (2007-03-01)

Male BRCA mutation carriers: clinical characteristics and cancer spectrum
by: Mohammed Ibrahim, et al.
Published: (2018-02-01)

Can harmful lifestyle, obesity and weight changes increase the risk of breast cancer in BRCA 1 and BRCA 2 mutation carriers? A Mini review
by: A. Daniele, et al.
Published: (2021-10-01)